# Efficacy and Safety of HILOTERM® Device for the Prevention of Peripheral Neuropathy

> **NCT06422949** · NA · NOT_YET_RECRUITING · sponsor: **European Institute of Oncology** · enrollment: 120 (estimated)

## Conditions studied

- Breast Cancer
- Neuropathy;Peripheral

## Interventions

- **DEVICE:** Hilotherm® Cooling treatment

## Key facts

- **NCT ID:** NCT06422949
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-06-15
- **Primary completion:** 2027-08-15
- **Final completion:** 2027-08-15
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06422949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06422949, "Efficacy and Safety of HILOTERM® Device for the Prevention of Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06422949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*